Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Recent News

08.09 2018
Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements
07.09 2018
Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases
06.27 2018
Translate Bio Announces Pricing of Initial Public Offering
06.18 2018
Translate Bio Launches Proposed Initial Public Offering

View All

@TranslateBio